Markus Mandler

1.8k total citations
28 papers, 1.4k citations indexed

About

Markus Mandler is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Markus Mandler has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 11 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Markus Mandler's work include Alzheimer's disease research and treatments (18 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Markus Mandler is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Markus Mandler collaborates with scholars based in Austria, United States and Germany. Markus Mandler's co-authors include Annette Neubüser, Achim Schneeberger, Abdallah Souabni, Meinrad Busslinger, Maxime Bouchard, Frank Mattner, Radmila Santic, Wolfgang Schmidt, Eliezer Masliah and Anthony Adame and has published in prestigious journals such as Genes & Development, PLoS ONE and Development.

In The Last Decade

Markus Mandler

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Mandler Austria 16 645 492 427 267 266 28 1.4k
Camelia‐Maria Monoranu Germany 20 402 0.6× 151 0.3× 339 0.8× 241 0.9× 155 0.6× 54 1.4k
René Günther Germany 18 398 0.6× 107 0.2× 459 1.1× 155 0.6× 122 0.5× 74 1.1k
Inge Van Hove Belgium 22 596 0.9× 143 0.3× 70 0.2× 295 1.1× 305 1.1× 38 1.4k
Tatyana Veremeyko United States 18 980 1.5× 233 0.5× 106 0.2× 622 2.3× 143 0.5× 22 2.0k
Yueshan Piao China 18 694 1.1× 184 0.4× 385 0.9× 118 0.4× 152 0.6× 60 1.4k
Maria Grazia Biferi France 15 446 0.7× 259 0.5× 203 0.5× 55 0.2× 97 0.4× 26 902
Chia-Yi Kuan United States 19 402 0.6× 100 0.2× 77 0.2× 257 1.0× 120 0.5× 37 981
Marie Bernadette Delisle France 15 457 0.7× 175 0.4× 240 0.6× 200 0.7× 125 0.5× 30 898
Becky Liu United Kingdom 12 1.1k 1.7× 258 0.5× 120 0.3× 77 0.3× 394 1.5× 23 1.6k
Ahdeah Pajoohesh‐Ganji United States 22 430 0.7× 188 0.4× 65 0.2× 167 0.6× 247 0.9× 31 1.6k

Countries citing papers authored by Markus Mandler

Since Specialization
Citations

This map shows the geographic impact of Markus Mandler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Mandler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Mandler more than expected).

Fields of papers citing papers by Markus Mandler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Mandler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Mandler. The network helps show where Markus Mandler may publish in the future.

Co-authorship network of co-authors of Markus Mandler

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Mandler. A scholar is included among the top collaborators of Markus Mandler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Mandler. Markus Mandler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Golombek, Sonia, Thomas Hoffmann, Ludmilla Hann, et al.. (2023). Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNA. Molecular Therapy — Nucleic Acids. 33. 642–654. 6 indexed citations
2.
Schmidhuber, Sabine, Sandra Scheiblhofer, Richard Weiss, et al.. (2022). A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice. Vaccines. 10(9). 1432–1432. 8 indexed citations
3.
Hochmann, Sarah, Radmila Santic, Frieder Koszik, et al.. (2018). Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer. Scientific Reports. 8(1). 12954–12954. 12 indexed citations
4.
Landlinger, Christine, et al.. (2017). Combinatorial Vaccine against Complement Factor C5a and Amyloid Beta: A New Therapeutic Approach in Alzheimers Disease. Journal of Clinical & Cellular Immunology. 8(1). 1 indexed citations
5.
Schneeberger, Achim, Suzanne Hendrix, Markus Mandler, et al.. (2015). RESULTS FROM A PHASE II STUDY TO ASSESS THE CLINICAL AND IMMUNOLOGICAL ACTIVITY OF AFFITOPE® AD02 IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE. The Journal of Prevention of Alzheimer s Disease. 2(2). 1–12. 32 indexed citations
6.
Mandler, Markus, Radmila Santic, P. Gruber, et al.. (2015). Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines. PLoS ONE. 10(1). e0115237–e0115237. 26 indexed citations
7.
Landlinger, Christine, et al.. (2015). Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease. Journal of Neuroinflammation. 12(1). 150–150. 49 indexed citations
8.
Mandler, Markus, Elvira Valera, Edward Rockenstein, et al.. (2015). Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy. Molecular Neurodegeneration. 10(1). 10–10. 118 indexed citations
9.
Schneeberger, Achim, et al.. (2015). Active immunization therapies for Parkinson's disease and multiple system atrophy. Movement Disorders. 31(2). 214–224. 69 indexed citations
10.
Attems, Johannes, Lauren Walker, Radmila Santic, et al.. (2014). Pyroglutamylated Amyloid-beta correlates with Hyperphosphorylated Tau and Severity of Alzheimer's Disease. Journal of Neuropathology & Experimental Neurology. 73(6). 587–587. 1 indexed citations
11.
Mandler, Markus, Lauren Walker, Radmila Santic, et al.. (2014). Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease. Acta Neuropathologica. 128(1). 67–79. 50 indexed citations
12.
Mandler, Markus, Elvira Valera, Edward Rockenstein, et al.. (2014). Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials. Acta Neuropathologica. 127(6). 861–879. 188 indexed citations
13.
Schneeberger, Achim, Alexandra Kutzelnigg, & Markus Mandler. (2012). Parkinson’s disease vaccine: clinical trial challenges when striving for disease modification. Clinical Investigation. 3(1). 1–4. 1 indexed citations
14.
Schneeberger, Achim, Markus Mandler, Frank Mattner, & Wolfgang Schmidt. (2011). Vaccination for Parkinson's disease. Parkinsonism & Related Disorders. 18. S11–S13. 57 indexed citations
15.
Schneeberger, Achim, Markus Mandler, Frank Mattner, & Walter Schmidt. (2010). AFFITOME® technology in neurodegenerative diseases: The doubling advantage. Human Vaccines. 6(11). 948–952. 42 indexed citations
16.
Schneeberger, Achim, Markus Mandler, Wolfgang Zauner, Frank Mattner, & Walter Schmidt. (2009). P1‐273: Development of Alzheimer AFFITOPE vaccines ‐ from concept to clinical testing. Alzheimer s & Dementia. 5(4S_Part_9). 2 indexed citations
17.
Kuntner, Claudia, Adam Kesner, Martin Bauer, et al.. (2009). Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer’s Disease. Molecular Imaging and Biology. 11(4). 236–240. 73 indexed citations
18.
Mandler, Markus & Annette Neubüser. (2004). FGF signaling is required for initiation of feather placode development. Development. 131(14). 3333–3343. 60 indexed citations
19.
Bouchard, Maxime, Abdallah Souabni, Markus Mandler, Annette Neubüser, & Meinrad Busslinger. (2002). Nephric lineage specification by Pax2 and Pax8. Genes & Development. 16(22). 2958–2970. 399 indexed citations
20.
Mandler, Markus & Annette Neubüser. (2001). FGF Signaling Is Necessary for the Specification of the Odontogenic Mesenchyme. Developmental Biology. 240(2). 548–559. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Camelia‐Maria Monoranu Breakdown of academic impact, for papers by René Günther Breakdown of academic impact, for papers by Inge Van Hove Breakdown of academic impact, for papers by Tatyana Veremeyko Breakdown of academic impact, for papers by Yueshan Piao Breakdown of academic impact, for papers by Maria Grazia Biferi Breakdown of academic impact, for papers by Chia-Yi Kuan Breakdown of academic impact, for papers by Marie Bernadette Delisle Breakdown of academic impact, for papers by Becky Liu Breakdown of academic impact, for papers by Ahdeah Pajoohesh‐Ganji
Rankless by CCL
2026